Ligand Pharmaceuticals | LGND - Stock

Aktienkurs
207.78
Täglich Wechseln
-0.11 -0.05%
Monatlich
-10.35%
Jährlich
98.04%
Q2 Prognose
208.92




Stock Veränderung Datum
Amgen USD 6.19B 39M 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Baxter International USD 2.32B 84M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Enviri Corporation USD 173.28M 7.27M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.12B 46M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.91M 841K 2026-03
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.48B 179M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Pfizer USD 10.67B 13M 2026-03
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Veracyte USD 21.42M 870K 2026-03